Login
| TI Ref No : | 530154541 |
|---|---|
| Description : | Contract Awarded For Acquisition Of Tislelitsumabin (tevimbra) tislelizumab Is A Humanized Monoclonal Antibody Variant Of Immunoglobulin G4 (igg4) Against Pd-1. It Binds To The Extracellular Domain Of Human Pd-1 And Competitively Inhibits The Binding Of B |
| Date : | 2026-03-10 |
| Deadline : | 2026-04-16 |
| Document Type : | Contracts |
